Navigation Links
URAC Announces Four More Companies in Process to Earn New Pharmacy Quality Management Accreditations
Date:2/11/2008

WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- URAC announced today that four more organizations are on track to earn its accreditation for Pharmacy Benefit Management and/or Drug Therapy Management, a range of pharmacy management services designed to optimize therapeutic outcomes for individual consumers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO )

URAC is the Washington, D.C.-based independent accreditor which offers more than 20 accreditation and certification programs along the continuum of care. Currently URAC accredits more than 400 health care management organizations operating in all 50 states.

URAC's Pharmacy Quality Management Program standards, developed concurrently with the Pharmacy Benefit Management standards and released in 2007, are designed to help organizations drive appropriate therapeutic outcomes for consumers with a clear focus on patient safety, outcomes measurement and quality improvement. They address a broad range of functions, such as development of clinical policies using evidence-based medicine; patient communication regarding medication use; and promoting consumer rights, shared decision making and education.

"These companies are at the forefront of this industry sector, and have stepped out voluntarily to seek a rigorous evaluation of their operations," said Alan P. Spielman, URAC's president and CEO. "Accreditation is a validation that companies are committed to quality and are willing to be accountable throughout their operations."

URAC's Pharmacy Quality Management Accreditation Programs are applicable to a broad range of health management organizations--pharmacy benefit management companies, or care management companies with oversight of a clinical Drug Therapy Management program, such as case management or disease management organizations. The companies that are In-Process are:

Diplomat Specialty Pharmacy (Drug Therapy Management and Disease Management accreditations); MaxorPlus, Ltd. (Pharmacy Benefit Management and Drug Therapy Management accreditations); MemberHealth, LLC, a subsidiary of Universal American Corp. (Pharmacy Benefit Management and Drug Therapy Management accreditations); and UnitedHealth Pharmaceutical Solutions, a division of United HealthCare Services, Inc. (Pharmacy Benefit Management and Drug Therapy Management accreditations)

"The emphasis on patient safety and continuous quality improvement these companies must demonstrate to become accredited sets them apart as leaders in the field," said Christine G. Leyden, RN, MSN, URAC's chief accreditation officer. "Consumers and purchasers can be assured the URAC seal means accredited organizations demonstrate ongoing accountability and a dedicated focus on quality."

For more information about URAC's Pharmacy Quality Management Accreditation Programs go to http://www.pbm.urac.org

About URAC

URAC, an independent, nonprofit organization, is well-known as a leader in promoting health care quality through its accreditation and education programs. URAC offers a wide range of quality benchmarking programs and services that keep pace with the rapid changes in the health care system, and provide a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire health care industry. For more information, visit http://www.urac.org.


'/>"/>
SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... concussions have on the growing brains of young athletes. Over the course of three ... the head through unique mouth guards. The mouth guards, equipped with special sensors, will ...
(Date:12/5/2016)... NY (PRWEB) , ... December 05, 2016 , ... ... to use a patent-pending blend of L-Citrulline and glutathione to enhance production of ... a combination that studies have shown to produce NO twice as effectively and ...
(Date:12/5/2016)... ... December 05, 2016 , ... Eating disorders ... goal of Castlewood Treatment Centers has always been to promote the power of ... people as possible. In that spirit, Castlewood has announced two new hires, both ...
(Date:12/5/2016)... ... December 05, 2016 , ... U.S. Apple Association (USApple) ... part of the second annual Apples for Education: Buy an Apple, Help a ... providing healthy food for students to take home to their families; solar technology to ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... was previously a subsidiary of Chiltern International and focuses on clinical trial ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... India , December 5, 2016 According ... by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free ... published by MarketsandMarkets, the market is projected to reach USD 779.8 ... a CAGR of 13.5% during the forecast period of 2016 to ... ...
(Date:12/5/2016)... and PUNE, India , December 5, ... by Allied Market Research, titled, "Global Cancer Biomarkers Market - ... of cancer biomarkers market is projected to reach $15,737 million ... of 13.3% from 2016 to 2022. Omic technologies segment accounted ... and is expected to maintain its dominance during the forecast ...
(Date:12/5/2016)...  CVS Health, the nation,s largest pharmacy innovation company, ... of 100 percent on the Corporate Equality Index (CEI) ... annual national benchmarking survey and report on corporate policies ... Human Rights Campaign Foundation. "Our company,s ... customers and suppliers bring to CVS Health," said ...
Breaking Medicine Technology: